Treatment.com AI and Rocket Doctor Celebrate Recognition from UC Berkeley, Harvard, and AARP for Leadership in Health Innovation
Treatment.com AI (CSE: TRUE, OTC: TREIF) and its virtual care platform, Rocket Doctor, have received recognition from three prestigious healthcare innovation organizations. The company was selected for UC Berkeley's Health Engine non-dilutive accelerator program for high-impact healthcare startups. At Harvard University, CEO Dr. William Cherniak was invited to speak about Rocket Doctor's transformation of healthcare delivery through virtual care, AI, and connected devices. Additionally, at the AARP AgeTech Conference, Dr. Cherniak presented the company's approach to improving care for Medicaid and Medicare patients.
These recognitions follow Rocket Doctor's recent award as Clinical Innovator of the Year at the American Telemedicine Association's NEXUS 2025 Innovators Challenge. The company focuses on using technology to reduce barriers to care and streamline access for underserved populations.
Treatment.com AI (CSE: TRUE, OTC: TREIF) e la sua piattaforma di assistenza virtuale, Rocket Doctor, hanno ricevuto riconoscimenti da tre prestigiose organizzazioni dedicate all'innovazione sanitaria. L'azienda è stata selezionata per il programma di accelerazione non diluitivo Health Engine dell'UC Berkeley, rivolto a startup sanitarie ad alto impatto. All'Università di Harvard, il CEO Dr. William Cherniak è stato invitato a parlare della trasformazione dell'assistenza sanitaria grazie a Rocket Doctor, che integra cure virtuali, intelligenza artificiale e dispositivi connessi. Inoltre, alla Conferenza AARP AgeTech, il Dr. Cherniak ha presentato l'approccio dell'azienda per migliorare l'assistenza ai pazienti Medicaid e Medicare.
Questi riconoscimenti seguono il recente premio ricevuto da Rocket Doctor come Innovatore Clinico dell'Anno durante la NEXUS 2025 Innovators Challenge organizzata dall'American Telemedicine Association. L'azienda si concentra sull'uso della tecnologia per abbattere le barriere all'accesso alle cure e semplificare l'assistenza per le popolazioni svantaggiate.
Treatment.com AI (CSE: TRUE, OTC: TREIF) y su plataforma de atención virtual, Rocket Doctor, han sido reconocidos por tres prestigiosas organizaciones de innovación en salud. La empresa fue seleccionada para el programa acelerador no dilutivo Health Engine de UC Berkeley, dirigido a startups de salud de alto impacto. En la Universidad de Harvard, el CEO Dr. William Cherniak fue invitado a hablar sobre cómo Rocket Doctor está transformando la prestación de servicios de salud mediante la atención virtual, la inteligencia artificial y dispositivos conectados. Además, en la Conferencia AARP AgeTech, el Dr. Cherniak presentó el enfoque de la empresa para mejorar la atención a pacientes de Medicaid y Medicare.
Estos reconocimientos se suman al reciente premio otorgado a Rocket Doctor como Innovador Clínico del Año en el Desafío de Innovadores NEXUS 2025 de la American Telemedicine Association. La empresa se enfoca en utilizar la tecnología para reducir las barreras al acceso a la atención y facilitar el acceso para poblaciones desatendidas.
Treatment.com AI (CSE: TRUE, OTC: TREIF)와 가상 진료 플랫폼 Rocket Doctor가 세 곳의 권위 있는 헬스케어 혁신 기관으로부터 인정을 받았습니다. 회사는 영향력 있는 헬스케어 스타트업을 위한 UC 버클리의 비희석형 액셀러레이터 프로그램 Health Engine에 선정되었습니다. 하버드 대학교에서는 CEO 윌리엄 체르니악 박사가 가상 진료, 인공지능, 연결된 기기를 통해 헬스케어 서비스를 혁신하는 Rocket Doctor에 대해 강연했습니다. 또한, AARP AgeTech 컨퍼런스에서 체르니악 박사는 메디케이드 및 메디케어 환자들의 치료 개선을 위한 회사의 접근법을 발표했습니다.
이러한 인정은 최근 Rocket Doctor가 미국 원격의료 협회(American Telemedicine Association)의 NEXUS 2025 혁신가 챌린지에서 올해의 임상 혁신가 상을 수상한 데 이은 것입니다. 이 회사는 기술을 활용해 치료 접근 장벽을 줄이고 소외된 인구의 접근성을 간소화하는 데 주력하고 있습니다.
Treatment.com AI (CSE : TRUE, OTC : TREIF) et sa plateforme de soins virtuels, Rocket Doctor, ont été reconnus par trois organisations prestigieuses d'innovation en santé. L'entreprise a été sélectionnée pour le programme d'accélération non dilutif Health Engine de l'UC Berkeley, destiné aux startups à fort impact dans le domaine de la santé. À l'Université Harvard, le PDG Dr William Cherniak a été invité à présenter la transformation des soins de santé grâce à Rocket Doctor, qui combine soins virtuels, intelligence artificielle et dispositifs connectés. De plus, lors de la Conférence AARP AgeTech, le Dr Cherniak a exposé l'approche de l'entreprise pour améliorer les soins aux patients Medicaid et Medicare.
Ces reconnaissances font suite au récent prix décerné à Rocket Doctor en tant qu'Innovateur Clinique de l'Année lors du défi des Innovateurs NEXUS 2025 de l'American Telemedicine Association. L'entreprise se concentre sur l'utilisation de la technologie pour réduire les obstacles aux soins et faciliter l'accès pour les populations mal desservies.
Treatment.com AI (CSE: TRUE, OTC: TREIF) und seine virtuelle Pflegeplattform Rocket Doctor wurden von drei angesehenen Organisationen für Innovation im Gesundheitswesen anerkannt. Das Unternehmen wurde für das nicht verwässernde Accelerator-Programm Health Engine der UC Berkeley ausgewählt, das sich an Healthcare-Startups mit hoher Wirkung richtet. An der Harvard University wurde CEO Dr. William Cherniak eingeladen, über die Transformation der Gesundheitsversorgung durch Rocket Doctor mittels virtueller Pflege, KI und vernetzter Geräte zu sprechen. Zudem stellte Dr. Cherniak auf der AARP AgeTech Conference den Ansatz des Unternehmens zur Verbesserung der Versorgung von Medicaid- und Medicare-Patienten vor.
Diese Anerkennungen folgen auf die kürzliche Auszeichnung von Rocket Doctor als Klinischer Innovator des Jahres bei der NEXUS 2025 Innovators Challenge der American Telemedicine Association. Das Unternehmen konzentriert sich darauf, mit Technologie Barrieren für die Versorgung abzubauen und den Zugang für unterversorgte Bevölkerungsgruppen zu erleichtern.
- None.
- None.
From classrooms to conferences, Rocket Doctor earns national spotlight for transforming virtual care delivery
●These accomplishments further position Rocket Doctor as a trusted, physician-led innovator in digital health, committed to reaching underserved communities with smarter, tech-enabled care.
●At UC Berkeley’s Health Engine, Rocket Doctor was selected as part of a competitive, non-dilutive accelerator focused on high-impact healthcare startups.
●At Harvard University, Dr. Cherniak was invited by Halle Tecco to speak to medical and business students about how Rocket Doctor is transforming healthcare delivery through virtual care, AI, and connected devices.
●At the AARP AgeTech Conference, Dr. Cherniak shared Rocket Doctor’s approach to improving care for Medicaid and Medicare patients across the U.S., emphasizing the platform’s role in addressing access, equity, and scalability for older adults.
TORONTO, ON, May 28, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) and its wholly owned virtual care platform, Rocket Doctor, are proud to announce that the company has recently been recognized by three of the most prestigious organizations in healthcare innovation: UC Berkeley’s Health Engine, Harvard University, and the AARP AgeTech Accelerator.
These distinctions reinforce Rocket Doctor’s position as a leading voice in comprehensive virtual care and demonstrate growing recognition of its physician-led, tech-driven model for transforming access to healthcare. It also further underscores Rocket Doctor recently being awarded Clinical Innovator of the Year at the American Telemedicine Association’s NEXUS 2025 Innovators Challenge.
As part of UC Berkeley’s Health Engine accelerator, Rocket Doctor joined a select cohort of healthtech founders building impactful solutions to today’s most pressing healthcare challenges. The non-dilutive, remote-first program provided expert mentorship, academic partnership, and strategic support to help accelerate mission and vision, gaining access to some of the world’s leading faculty in health policy and digital health, and further boosting its integration into the California ecosystem.
Following the Health Engine program, Dr. Cherniak was invited to speak at Harvard University, guest lecturing in a course led by Halle Tecco, course Director at Harvard Medical School, Adjunct Professor at Columbia Business School, and founder of Rock Health. During the session, Dr. Cherniak shared the Rocket Doctor journey, detailing how the platform empowers physicians with AI-enabled tools and diagnostic devices to deliver care efficiently, virtually, and at scale, answering questions from the class and engaging in discussions around health policy and digital innovation.
Dr. Cherniak was also invited to speak at the 2025 AARP AgeTech Conference, part of the AgeTech Collaborative™ from AARP, where he shared the Rocket Doctor story with a national audience of entrepreneurs, investors, and healthcare leaders. His presentation highlighted the company’s innovative approach to delivering comprehensive physician-led care, with a particular focus on supporting Medicaid and Medicare patients across the United States. As part of the conference’s thought leadership programming, Dr. Cherniak outlined how Rocket Doctor is using technology to reduce barriers to care, streamline access for underserved populations, and addressing the complex needs of aging Americans through scalable, virtual-first models.
“It’s an incredible privilege to engage with institutions like UC Berkeley, Harvard, and AARP - each of which plays a vital role in shaping the future of healthcare,” said Dr. William Cherniak, CEO of Rocket Doctor. “Being selected and invited by these organizations is a strong validation of our vision to make high-quality care radically more accessible through technology, AI, and physician leadership.”
Through these platforms, Rocket Doctor continues to build meaningful relationships with innovators, researchers, and decision-makers across the health ecosystem, further accelerating its mission to transform care delivery in North America and beyond.
About Rocket Doctor Inc.
Rocket Doctor is a technology-driven digital health platform and marketplace that empowers doctors to build and manage their own virtual or hybrid practices. Its proprietary software and AI-powered tools enable providers to deliver high-quality comprehensive care remotely, with a focus on reaching underserved and remote communities across North America. By removing barriers to care and restoring physician autonomy, Rocket Doctor is redefining what modern healthcare looks like.
Visit www.rocketdoctor.io or contact media@rocketdoctor.io.
About Treatment.com AI Inc.
Treatment.com AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, Treatment.com AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. Treatment.com AI’s GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities.
Learn more at: www.treatment.com or contact info@treatment.com.
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO – Treatment.com AI Inc.
Email: ehamza@treatment.com
Media inquiries: media@rocketdoctor.io
Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955
Cautionary Statement
This news release contains forward-looking statements that are based on Treatment.com AI’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although Treatment.com AI believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Treatment.com undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
FAQ
What recent recognitions has Treatment.com AI (TREIF) received in 2025?
What is Rocket Doctor's main focus in healthcare delivery?
Who is the CEO of Treatment.com AI's Rocket Doctor platform?
What was Treatment.com AI's role in UC Berkeley's Health Engine program?
